Nerve Block News and Research

RSS

Neuros Medical honored as most promising startup

Neuros Medical, Inc., a medical device company, was presented the 2012 Gold Electrode Award for Most Promising Startup at the Neurotech Leaders Forum conference in San Francisco. The award is given by Neurotech Reports, and highlights a company in the neuromodulation industry that holds the most promise.

29 Oct 2012

FDA clears Teleflex’s ARROW FlexBlock continuous peripheral nerve block catheter

Teleflex Incorporated today announced the ARROW FlexBlock continuous peripheral nerve block catheter has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

24 Sep 2012

$Study tests link between anesthesia type, complications and mortality after hip fracture surgery$

Study tests link between anesthesia type, complications and mortality after hip fracture surgery

Anesthesia type may affect complications and mortality after hip fracture surgery, according to a new study in the July issue of Anesthesiology. The Perelman School of Medicine at the University of Pennsylvania study tested the association between regional versus general anesthesia, and pulmonary and cardiovascular complications and mortality.

21 Jun 2012

Researchers describe how they combine two pieces of technology to create neuroprosthesis

An artificial connection between the brain and muscles can restore complex hand movements in monkeys following paralysis, according to a study funded by the National Institutes of Health.

19 Apr 2012

Terason receives FDA 510(k) clearance to use Soma's AxoTrack technology

Terason, the leading manufacturer of high-performance portable ultrasound systems and Soma Access Systems LLC today announced that they have received 510(k) clearance from the FDA for a new transducer equipped with AxoTrack needle visualization technology.

21 Mar 2012

Study finds no clear advantage of ultrasound guidance for pain relief in nerve block procedures

Using ultrasound to guide the performance of nerve blocks—in which anesthetics are directly targeted to a specific nerve or group of nerves—has contributed to the increased use of regional anesthesia.

17 Sep 2011

Pacira second quarter total revenues increase to $3.6 million

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced financial results for the second quarter ended June 30, 2011, provided an update on the execution of its pre-commercial and launch strategies for EXPAREL, and updated its 2011 financial guidance.

11 Aug 2011

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced financial results for the first quarter ended March 31, 2011, provided an update on the execution of its pre-commercial and launch strategies for EXPAREL, and reiterated 2011 financial guidance.

11 May 2011

Pacira to present EXPAREL data in postsurgical pain at two medical meetings

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced that clinical and preclinical data highlighting the safety and efficacy of EXPAREL™ will be presented at two medical meetings.

6 May 2011

Top-line results from DURECT's ELADUR Phase II trial in chronic low back pain

DURECT Corporation announced today top-line results from a Phase II clinical trial in chronic low back pain for ELADUR, DURECT's proprietary investigational transdermal bupivacaine pain patch.

12 Apr 2011

Positive results from Neuros Medical Electrical Nerve Block technology study in chronic pain

Neuros Medical, Inc., a medical device company, announced promising results today from their recently completed feasibility study. The study was the first human test of the Company's patented high frequency Electrical Nerve Block™ technology and focused on patients with chronic amputation pain which affects nearly one million patients in the U.S. During the study, four of the five patients reported their pain was reduced to zero.

7 Apr 2011

Pacira reports net loss of $7.0 million for quarter ended December 31, 2010

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced financial results for the fourth quarter and full-year ended December 31, 2010, provided an update on the execution of its pre-commercial and launch strategies for EXPAREL and established 2011 financial guidance.

31 Mar 2011

Neuros Medical announces initial feasibility study results of HFAC Nerve Block technology

Neuros Medical, Inc., a medical device company announced today initial feasibility study results of their patented high frequency alternating current (HFAC) Nerve Block technology from their first patient. The study is a short-term, 30-day test per patient, focusing on chronic residual limb pain. Nearly one million patients suffer from chronic residual limb pain in the U.S.

20 Jan 2011

Masimo's noninvasive SpMet provides measurements comparable to invasive methemoglobin testing

Masimo announced today that a new clinical study published in Anesthesia & Analgesia demonstrates that Masimo noninvasive and continuous methemoglobin (SpMet®) measurements provide a high degree of agreement in measurements with corresponding laboratory values of methemoglobin obtained by invasive methemoglobin testing. In addition, the authors concluded that SpMet could facilitate early diagnosis and treatment of methemoglobinemia during high-risk procedures.

22 Sep 2010

Surgical robots could be used for teleanesthesia: Study

An existing surgical robot could be used to perform complex regional anesthesia procedures—in theory, allowing expert anesthesiologists to perform robot-assisted procedures from remote locations, according to a study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

27 Aug 2010

Pancreas surgery specialist performs 1,000th Whipple procedure

Pancreas surgery specialist Charles J. Yeo, M.D., Samuel D. Gross Professor and Chair, Department of Surgery at Jefferson Medical College of Thomas Jefferson University, and Co-Director of the Pancreatic, Biliary Tract and Related Cancer Center at Thomas Jefferson University Hospital, recently performed his 1,000th Whipple procedure (pancreaticoduodenectomy). Only one other surgeon in the United States has reached this milestone for this procedure. That surgeon is John Cameron, M.D., Professor, Department of Surgery at The Johns Hopkins Hospital.

30 Jul 2010

Neuros Medical receives $1.5M Applied Research and Technology Development Award from DMRDP

Neuros Medical, Inc., a medical device company announced today they have received notification of award for $1.5 million from the U.S. Department of Defense. The Applied Research and Technology Development Award was provided by the Defense Medical Research and Development Program (DMRDP).

2 Jul 2010

New approach may prove useful in labor anesthesia, orthopedics and more

One of the holy grails of local anesthesia is the ability to achieve a long-lasting nerve block that eliminates pain sensation while not affecting motor function. Now, researchers at Children's Hospital Boston have discovered an anesthetic approach that seems to do just that.

2 Feb 2010

Neuros Medical announces $1.8 million series A round of investment

Neuros Medical, Inc., a medical device company developing innovative neurostimulation technology for the treatment of chronic pain, announced today a $1.8 million series A round of investment, led by the North Coast Angel Fund (NCAF), which was joined in the investment by Glengary LLC, Ohio Tech Angel Fund, Queen City Angels First Fund III, and individual investors. This round follows the initial investment made earlier in the year from JumpStart Ventures and Case Technology Ventures.

24 Oct 2009

Regional nerve block anesthesia improve recovery, outcomes

When planning for surgery, patients too often don't consider the kind of anesthesia they will receive. In fact, the choice of anesthesia can improve recovery, even outcomes.

4 Aug 2009